50195-7
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript [Log Number Ratio] in Blood or Tissue by Molecular genetics method
Active
Term Description
BCR/ABL Ratio.
(BCR=Breakpoint Cluster Region and ABL=Abelson) The level of fusion gene transcript in the test sample is expressed as a log reduction; i.e., log10 of the ratio of chimeric BCR-ABL/normal ABL mRNA transcript seen in individuals with untreated CML (Chronic Myelogenous Leukemia) as compared to the ratio seen in the patient. In Quest's laboratory data, the median of BCR-ABL/ABL Ratio in previously untreated CML patients is 4.1325 in peripheral blood samples (N=120) and 5.09 in bone marrow samples (N=109). Based on the IRIS study (New England Journal of Medicine, 2003, 3349:1423-1432), it is not necessary to know the BCR-ABL:ABL ratio of a patient at baseline to calculate the subsequent change and this calculation should be based on the above-mentioned median. Based on this study, a 3 log of higher reduction by 12 months of therapy is associated with negligible risk of disease progression during the subsequent 12 months with patients are treated with imatinib. The following formula is used for calculating log reduction by Quest Laboratories: LOG10(4.1325)-LOG10 (BCR-ABL:ABL ratio) Unit/Log Reduction. Information from Quest Diagnostics. 2006 12 06.
Source: Regenstrief Institute
Part Description
LP150238-6 t(9;22)(q34.1;q11)(ABL1,BCR)
Chronic myelogenous leukemia (CML), acute lymphoblastic leukemia (ALL), and acute myeloid leukemia (AML) are associated with the fusion of the breakpoint cluster gene (BCR) at chromosome 22q11 to the Abelson gene (ABL1) at chromosome 9q23. The t(9;22)(BCR-ABL1) gene translocation leads to the cytogenetic finding known as the Philadelphia chromsome (Ph'). Various breakpoints within the BCR and ABL1 genes have been described. Most cases of CML are due to a fusion of BCR exon 13 (e13 or b2) or BCR exon 14 (e14 or b3) to the ABL exon 2 (a2). The b2a2 (e13a2) and b3a2 (e14a2) fused transcripts, also known as major break points, produce a 210-kDa protein (p210). The fused transcript resulting in a 190-kDa protein (e1a2 or less common e1a3), also known as minor break points, is found in approximately 75% of childhood ALL patients and 50% of adult ALL patients. Other rarely reported fused transcripts include e6a2, e19a2 (p230), e13a3, and e14a3.
Source: Regenstrief LOINC
LOINC Names Get Info
- Fully-Specified Name
- t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript:
LnRto: Pt: Bld/Tiss: Qn: Molgen - Long Common Name
- t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript [Log Number Ratio] in Blood or Tissue by Molecular genetics method
- Short Name
- t(9;22)(ABL1,BCR)/control Bld/T-LnRto
- Display Name
- t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript Molgen (Bld/Tiss) [Log # ratio]
- Consumer Name Alpha Get Info
- t(9;22)(q34.1;q11)(ABL1,BCR)/control Transcript, Blood or tissue specimen
Part Model Get Info
- Component
- t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript
LP287185-5
- Analyte
- t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript
LP287185-5
- Component Numerator
- t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript
LP174091-1
- Component Numerator Core
- t(9;22)(q34.1;q11)(ABL1,BCR)
LP150238-6
- Component Numerator Core Suffix
- fusion transcript
LP150217-0
- Component Denominator
- control transcript
LP150246-9
- Component Denominator Core
- control transcript
LP150246-9
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- LnRto
LP65260-9
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Bld/Tiss
LP7061-7
- System Core
- Bld/Tiss
LP7061-7
- Super System
- NULL
- Scale
- Qn
LP7753-9
- Method
- Molgen
LP6404-0
Basic Attributes
- Class
- MOLPATH.TRNLOC
- Type
- Laboratory
- First Released
- Version 2.22
- Last Updated
- Version 2.73 (MIN)
- Change Reason
- Component part BCR/ABL for this term was erroneous. Edited to represent what is really being measured and to harmonize with current LOINC nomenclature.
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 12833
Formula (Readable)
LOG10(4.1325)-LOG10(BCR-ABL:ABL ratio) Unit/Log Reduction
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Fúzní transkript t(9; |
| el-GR | Greek (Greece) | t(9; Synonyms: LnRto MOLPATH MOLPATH.TRNLOC Pt Qn t(9; |
| es-ES | Spanish (Spain) | t(9; Synonyms: Cuantitativo |
| es-MX | Spanish (Mexico) | t (9; |
| fr-CA | French (Canada) | t(9; |
| fr-FR | French (France) | t(9; |
| it-IT | Italian (Italy) | t(9,22)(q34.1,q11)(ABL1,BCR), trascritto di fusione/trascritto di controllo: Synonyms: Genetica molecolare Patologia molecolare Punto nel tempo (episodio) Rapporto logaritmico Sangue Sangue o Tessuto Tessuto & |
| nl-NL | Dutch (Netherlands) | t(9; Synonyms: molgen |
| pl-PL | Polish (Poland) | t(9; Synonyms: diagnostyka molekularna |
| pt-BR | Portuguese (Brazil) | BCR-ABL: Synonyms: Log number ratio; |
| ru-RU | Russian (Russian Federation) | t(9; Synonyms: Количественный Кровь Кровь или Ткань Логарифмическое количеств отношение Ткань и мазки Точка во времени; |
| tr-TR | Turkish (Turkey) | t(9; |
| zh-CN | Chinese (China) | t(9; Synonyms: ABL CML JTK7 p150 v-abl Abelson murine leukemia viral oncogene homolog 1 v-abl Abelson 小鼠白血病病毒癌基因同源体 1 v-abl Abelson 小鼠白血病病毒肿瘤基因同源体 1 v-abl Abelson 小鼠白血病病毒致癌基因同源体 1 v-abl Abelson 鼠科动物白血病病毒致癌基因同源体 1 v-abl Abelson 鼠科白血病病毒致癌基因同源体 1 全血或组织; |
Example Units
| Unit | Source |
|---|---|
| {log_reduction} | Example UCUM Units |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://